CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
4.650
+0.010 (0.22%)
Apr 17, 2025, 4:00 PM EDT - Market closed

CARGO Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-167.5-98.15-40.95-5.85
Depreciation & Amortization
7.073.691.440.15
Loss (Gain) From Sale of Assets
0.16---
Asset Writedown & Restructuring Costs
0.31.511.01-
Loss (Gain) From Sale of Investments
-3.52---
Stock-Based Compensation
17.973.330.30.51
Other Operating Activities
-6.256.16-
Change in Accounts Payable
-2.10.762.820.33
Change in Other Net Operating Assets
7.871.450.15-0.08
Operating Cash Flow
-139.74-81.16-29.07-4.94
Capital Expenditures
-4.45-8.28-2.72-0.44
Sale of Property, Plant & Equipment
0.22---
Sale (Purchase) of Intangibles
-0.95-0.72-0.56-
Investment in Securities
-299.91---
Investing Cash Flow
-305.08-8.99-3.28-0.44
Short-Term Debt Issued
-3.528.45-
Total Debt Issued
-3.528.45-
Net Debt Issued (Repaid)
-3.528.45-
Issuance of Common Stock
104.06296.640.23-
Other Financing Activities
-0.59-5.47--
Financing Cash Flow
103.47494.5834.195.41
Net Cash Flow
-341.35404.431.830.03
Free Cash Flow
-144.19-89.44-31.8-5.38
Free Cash Flow Per Share
-3.21-15.06-81.06-35.32
Levered Free Cash Flow
-93.51-68.1-7.91-
Unlevered Free Cash Flow
-93.51-67.1-4.82-
Change in Net Working Capital
-3.954.68-18.45-
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q